Covidien receives FDA clearance for LigaSure Maryland jaw Covidien received U.S. Food and Drug Administration 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic sealer/divider. In addition, Covidien completed all European requirements to CE Mark the product. The company expects to launch the new vessel sealer and divider in the U.S. and the European Union during the current quarter. Covidien plans to roll out the 37 cm version to select customers early in 2014 and launch the shorter 23 cm and longer 44 cm options later this year.
News For COV From The Last 14 Days
Check below for free stories on COV the last two weeks.